Albert David Limited (ALBERTDAVD.NS)
- Previous Close
810.15 - Open
810.00 - Bid 811.50 x --
- Ask 812.75 x --
- Day's Range
803.05 - 816.95 - 52 Week Range
762.60 - 1,753.95 - Volume
2,840 - Avg. Volume
9,676 - Market Cap (intraday)
4.634B - Beta (5Y Monthly) -0.04
- PE Ratio (TTM)
26.94 - EPS (TTM)
30.14 - Earnings Date Aug 4, 2025 - Aug 8, 2025
- Forward Dividend & Yield 5.00 (0.62%)
- Ex-Dividend Date Jul 24, 2025
- 1y Target Est
--
Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India. It offers formulations for parenterals, oral/enteral, topical agents, and vision care products. The company exports its products to Latin American, Southeast Asian, and other African countries. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India.
www.albertdavidindia.com--
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: ALBERTDAVD.NS
View MorePerformance Overview: ALBERTDAVD.NS
Trailing total returns as of 5/22/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALBERTDAVD.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALBERTDAVD.NS
View MoreValuation Measures
Market Cap
4.62B
Enterprise Value
--
Trailing P/E
26.88
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.34
Price/Book (mrq)
1.18
Enterprise Value/Revenue
0.42
Enterprise Value/EBITDA
6.93
Financial Highlights
Profitability and Income Statement
Profit Margin
4.98%
Return on Assets (ttm)
-0.49%
Return on Equity (ttm)
4.44%
Revenue (ttm)
3.46B
Net Income Avi to Common (ttm)
172.01M
Diluted EPS (ttm)
30.14
Balance Sheet and Cash Flow
Total Cash (mrq)
2.44B
Total Debt/Equity (mrq)
3.14%
Levered Free Cash Flow (ttm)
-374.72M